Evidence map›Paper›PMID 24227722›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2013

D1 dopamine receptor coupling to PLCβ regulates forward locomotion in mice.

Ivan O Medvedev, Amy J Ramsey, Shababa T Masoud, Marie Kristel Bermejo, Nikhil Urs, Tatyana D Sotnikova, Jean-Martin Beaulieu, Raul R Gainetdinov, Ali Salahpour

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. G Protein-Coupled Receptor Dimerization-What Next?International journal of molecular sciences · 2024
    Review
  3. Article
  4. Article
  5. Dopamine, Immunity, and Disease.Pharmacological reviews · 2023
    Review
  6. Article
  7. Selective Manipulation of G-Protein γThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2021
    Article
  8. Dopamine ModulatesBiology · 2021
    Article
  9. Article
  10. Maladaptive consequences of repeated intermittent exposure to uncertainty.Progress in neuro-psychopharmacology & biological psychiatry · 2020
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 4 countries.

Ivan O MedvedevDepartment of Cell Biology, Duke University Medical Center, Durham, North Carolina 27710, Department of Pharmacology and Toxicology, Faculty of Medicine, University of Toronto, Toronto, Ontario M5S 1A8, Canada, Department of Neuroscience and Brain Technologies, Istituto Italiano di Tecnologia, 16163 Genova, Italy, Skolkovo Institute of Science and Technology, Skolkovo, Moscow Region, 143025, Russia, Faculty of Biology and Soil Science, St. Petersburg State University, St. Petersburg 199034, Russia, and Department of Psychiatry and Neuroscience, Faculty of Medicine, Laval University and Institut Universitaire en Santé Mentale de Québec, Québec City, Québec G1J 2G3, Canada.
Amy J Ramsey
Shababa T Masoud
Marie Kristel Bermejo
Nikhil Urs
Tatyana D Sotnikova
Jean-Martin Beaulieu
Raul R Gainetdinov
Ali Salahpour
University of Toronto · CADuke Medical Center · USInstitut Universitaire en Santé Mentale de Québec · CAItalian Institute of Technology · ITSkolkovo Institute of Science and Technology · RUSt Petersburg University · RU

Funding

CARDIOVASCULAR RESEARCH TRAINING PROGRAMT32HL007828 · NHLBI · UNIVERSITY OF WASHINGTON · PI Francis Kim, Farid Moussavi-Harami · 1997 to 2026
$10.2M
Toxicant evaluation in mice with selective dopamine transporter overexpressionK99ES016816 · NIEHS · DUKE UNIVERSITY · PI SALAHPOUR, ALI · 2008 to 2008
$54k
CIHR 210296CIHR 258294NHLBI NIH HHS T32 HL007828NIEHS NIH HHS 1K99ES016816-01NIEHS NIH HHS K99 ES016816
6 · The paper itself

Abstract

Several studies have reported the coupling of dopamine signaling to phospholipase C β (PLCβ) both in vitro and in vivo. However, the precise physiological relevance of this signaling pathway in mediating dopamine behaviors is still unclear. Here we report that stimulation of dopamine receptor signaling in vivo with systemic administration of apomorphine, amphetamine, and cocaine leads to increased production of inositol triphosphate (IP3) in the mouse striatum. Using selective antagonists and dopamine D1 and D2 receptor knock-out animals, we show that the production of IP3 is mediated by the D1 receptor, but not the D2 receptor. A selective blocker of PLCβ, U73122, was used to assess the physiological relevance of D1-mediated IP3 production. We show that U73122 inhibits the locomotor-stimulating effects of apomorphine, amphetamine, cocaine, and SKF81297. Furthermore, U73122 also suppresses the spontaneous hyperactivity exhibited by dopamine transporter knock-out mice. Importantly, the effects of U73122 are selective to dopamine-mediated hyperactivity, as this compound does not affect hyperactivity induced by the glutamate NMDA receptor antagonist MK801. Finally, we present evidence showing that an imbalance of D1- and D2-mediated signaling following U73122 treatment modifies the locomotor output of animals from horizontal locomotor activity to vertical activity, further highlighting the importance of the PLCβ pathway in the regulation of forward locomotion via dopamine receptors.

Indexed as

AnimalsFemaleMaleMiceMice, Inbred C57BLMice, KnockoutMotor ActivityPhospholipase C betaProtein BindingReceptors, Dopamine D1Phospholipase C betaReceptors, Dopamine D1

Identifiers

PMID24227722
PMCPMC3828465
OpenAlexW2016773078

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.